Amgen Stock (AMGN) Today: Q3 2025 Earnings Beat, MariTide Obesity Drug Outlook and 2030 Price Forecast
Updated December 1, 2025 Amgen stock at a glance on December 1, 2025 Amgen Inc. (NASDAQ: AMGN) closed today at $337.49, down about 2.3% on the session, according to real‑time quote data. StockAnalysis Despite today’s pullback, the stock has had a powerful run: Zacks notes that Amgen shares are up almost 16% over the past month, significantly outpacing the broader healthcare sector. TradingView Benzinga pegs Amgen’s 2025 year‑to‑date return at roughly 31% and 1‑year return at about 20%, with a market cap around $184–186 billion. Benzinga+2Ticker Nerd+2 Intraday, Amgen was one of the main drags on the Dow: MarketWatch highlighted